ADRX
ADARx Pharmaceuticals, Inc. · NASDAQ:ADRX
16.45 USD−0.5450 −3.21%
ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX) last traded at 16.45 USD, down 3.21% on the day. Over the past year the stock is down 25.54%. Its 52-week range is 16.30 to 23.21. It is in the Health Technology sector (Biotechnology).
Key statistics
Open16.95
Day range16.43 – 17.03
52-week range16.30 – 23.21
Volume137.09 K
Average volume (10 days)361.48 K
Market cap1.82 B
Dividend yield0.00%
Beta (1 year)−0.6717
Performance
−7.40%1 week
−14.79%1 month
−25.54%3 months
−25.54%6 months
−25.54%Year to date
−25.54%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- ADARx Pharmaceuticals Initiated at Buy by TD CowenDow Jones Newswires · 20 Oct 2026
- ADARx Pharmaceuticals Initiated at Overweight by JP MorganDow Jones Newswires · 20 Oct 2026
- ADARx Pharmaceuticals Initiated at Buy by UBSDow Jones Newswires · 20 Oct 2026
- ADARx Pharmaceuticals Initiated at Overweight by Morgan StanleyDow Jones Newswires · 20 Oct 2026
- Simeon George Discloses Investment at ADARx Pharmaceuticals with 9.3% StakeTradingView · 05 Oct 2026
- OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% StakeTradingView · 02 Oct 2026
- ADARx Pharmaceuticals, Inc. (ADRX) Greenshoe Fully Exercised; IPO Gross Proceeds ~$513.2MTradingView · 01 Oct 2026
- ADARx Pharmaceuticals surges following upsized IPOSeeking Alpha · 25 Sep 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.